HANNAH RODDENBERRY: Open Payments
NPI 1437828969 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 41 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $441 · 2025 $1,219
Food & beverage: $1,119Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $310 |
| REVANCE THERAPEUTICS, INC. | 2 | $195 |
| Regeneron Healthcare Solutions, Inc. | 5 | $187 |
| Incyte Corporation | 3 | $70 |
| UCB, Inc. | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $52 |
| LEO Pharma Inc. | 2 | $52 |
| Organon LLC | 2 | $49 |
| Amgen Inc. | 2 | $43 |
Products named: DUPIXENT, DAXI, DAXXIFY, OPZELURA, Bimzelx, TREMFYA, RINVOQ, ANZUPGO.
Industry payments across LA — which companies pay providers there.
